Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is it reasonable to use hypofractionation in breast cancer patients with non-active connective tissue disorders?
Answer from: Radiation Oncologist at Academic Institution
Yes, it is reasonable to use hypofractionation in this patient panel. I have used the Canadian fractionation schedule several times in this scenario.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
I’ve also routinely done this with no issue at all.
Sign in or Register to read more
15771
15793
Related Questions
What are your top takeaways in Medical Oncology from SABCS 2024?
Would you consider radiation omission for a patient with a Stage I breast cancer with an elevated Oncotype Dx?
When using FAST Forward, how important is it for the treatment to be delivered Monday through Friday in one week as opposed to spanning a weekend?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Do you hold endocrine therapy during adjuvant breast radiotherapy?
Why do we tend to boost grade 3 DCIS, but not grade 1 invasive disease?
In the post-mastectomy setting, are there situations where only the regional nodes or targeted nodal basis are covered?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?
What evidence supports the use of high tangents for pN1mic breast cancer?